I am proud that we were able to work together in such a strong bipartisan fashion on this legislation.
Editor's note · Context
Waxman highlights bipartisan cooperation on the Generic Drug and Biosimilars User Fee Act.
Share
More from Henry Waxman
The $200 billion in the Waxman-Markey bill that passed the House of Representatives was turned down over here in the Senate.
We need to make sure that companies and regulators can keep pace with innovation.
I hope this committee will initiate a detailed investigation examining this network of front groups and trade associations, determine who funds them and expose how they coordinate with industry.
I want to take this opportunity to pay tribute to Ralph Hall, particularly for his earlier years in the House of Representatives when he was a Democrat. He came on the Energy and Commerce Committee early. We sometimes think about Democrats…





